CN1786025B - 别藻蓝蛋白、晶体生产工艺及制品 - Google Patents
别藻蓝蛋白、晶体生产工艺及制品 Download PDFInfo
- Publication number
- CN1786025B CN1786025B CN 200410089528 CN200410089528A CN1786025B CN 1786025 B CN1786025 B CN 1786025B CN 200410089528 CN200410089528 CN 200410089528 CN 200410089528 A CN200410089528 A CN 200410089528A CN 1786025 B CN1786025 B CN 1786025B
- Authority
- CN
- China
- Prior art keywords
- allophycocyanin
- phosphate buffered
- crystal
- buffered saline
- saline buffer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 108010004469 allophycocyanin Proteins 0.000 title claims abstract description 229
- 239000013078 crystal Substances 0.000 title claims abstract description 77
- 238000004519 manufacturing process Methods 0.000 title description 4
- 238000005516 engineering process Methods 0.000 title description 3
- 238000002360 preparation method Methods 0.000 claims abstract description 16
- 239000000872 buffer Substances 0.000 claims description 74
- 239000002953 phosphate buffered saline Substances 0.000 claims description 65
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims description 57
- 239000000243 solution Substances 0.000 claims description 56
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims description 36
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 36
- 238000000034 method Methods 0.000 claims description 35
- 238000001556 precipitation Methods 0.000 claims description 33
- 238000004440 column chromatography Methods 0.000 claims description 29
- 239000006228 supernatant Substances 0.000 claims description 26
- 239000000047 product Substances 0.000 claims description 22
- 229920005654 Sephadex Polymers 0.000 claims description 18
- 239000012507 Sephadex™ Substances 0.000 claims description 18
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 claims description 17
- 238000005119 centrifugation Methods 0.000 claims description 17
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 14
- 238000010828 elution Methods 0.000 claims description 14
- 230000008569 process Effects 0.000 claims description 9
- 238000013019 agitation Methods 0.000 claims description 7
- 238000013467 fragmentation Methods 0.000 claims description 7
- 238000006062 fragmentation reaction Methods 0.000 claims description 7
- 238000007710 freezing Methods 0.000 claims description 7
- 230000008014 freezing Effects 0.000 claims description 7
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 7
- 238000001953 recrystallisation Methods 0.000 claims description 7
- 230000018109 developmental process Effects 0.000 claims description 4
- 238000007789 sealing Methods 0.000 claims description 3
- 238000005194 fractionation Methods 0.000 claims description 2
- 239000002244 precipitate Substances 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 1
- 229940095054 ammoniac Drugs 0.000 claims 1
- 241000195493 Cryptophyta Species 0.000 abstract description 14
- 102000004169 proteins and genes Human genes 0.000 abstract description 10
- 108090000623 proteins and genes Proteins 0.000 abstract description 10
- 238000001514 detection method Methods 0.000 abstract description 7
- 239000003814 drug Substances 0.000 abstract description 5
- 238000011160 research Methods 0.000 abstract description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 42
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 37
- 235000011130 ammonium sulphate Nutrition 0.000 description 37
- 239000007788 liquid Substances 0.000 description 33
- 210000004027 cell Anatomy 0.000 description 30
- 239000007787 solid Substances 0.000 description 21
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 19
- 235000001014 amino acid Nutrition 0.000 description 17
- 150000001413 amino acids Chemical class 0.000 description 17
- 238000006243 chemical reaction Methods 0.000 description 17
- 230000000694 effects Effects 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 238000000502 dialysis Methods 0.000 description 14
- 238000004321 preservation Methods 0.000 description 14
- 229920002307 Dextran Polymers 0.000 description 13
- 239000000178 monomer Substances 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 12
- 125000006850 spacer group Chemical group 0.000 description 12
- -1 propionic acid N-hydroxy-succinamide ester Chemical class 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- JWDFQMWEFLOOED-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 3-(pyridin-2-yldisulfanyl)propanoate Chemical compound O=C1CCC(=O)N1OC(=O)CCSSC1=CC=CC=N1 JWDFQMWEFLOOED-UHFFFAOYSA-N 0.000 description 10
- 239000001166 ammonium sulphate Substances 0.000 description 10
- 238000004587 chromatography analysis Methods 0.000 description 10
- 239000008176 lyophilized powder Substances 0.000 description 10
- 150000003016 phosphoric acids Chemical class 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- 235000018102 proteins Nutrition 0.000 description 9
- 108090001008 Avidin Proteins 0.000 description 8
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 8
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- 230000002035 prolonged effect Effects 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 210000001744 T-lymphocyte Anatomy 0.000 description 7
- 238000013016 damping Methods 0.000 description 7
- 239000012530 fluid Substances 0.000 description 7
- 239000000833 heterodimer Substances 0.000 description 7
- 101710153593 Albumin A Proteins 0.000 description 6
- 102000006410 Apoproteins Human genes 0.000 description 6
- 108010083590 Apoproteins Proteins 0.000 description 6
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 6
- 239000012043 crude product Substances 0.000 description 6
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 229920001184 polypeptide Polymers 0.000 description 6
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 102000004196 processed proteins & peptides Human genes 0.000 description 6
- 210000004881 tumor cell Anatomy 0.000 description 6
- 235000016425 Arthrospira platensis Nutrition 0.000 description 5
- 240000002900 Arthrospira platensis Species 0.000 description 5
- 241001062009 Indigofera Species 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- 238000010266 Sephadex chromatography Methods 0.000 description 5
- 238000002441 X-ray diffraction Methods 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 230000001093 anti-cancer Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 230000001186 cumulative effect Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000004090 dissolution Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 238000005374 membrane filtration Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 239000002808 molecular sieve Substances 0.000 description 5
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 5
- 239000012460 protein solution Substances 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 229940082787 spirulina Drugs 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 238000000967 suction filtration Methods 0.000 description 5
- 238000002525 ultrasonication Methods 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- LMUKJAZFWLIKCI-ARJAWSKDSA-N (z)-n'-ethylbut-2-enediamide Chemical compound CCNC(=O)\C=C/C(N)=O LMUKJAZFWLIKCI-ARJAWSKDSA-N 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 229940098773 bovine serum albumin Drugs 0.000 description 4
- 238000003018 immunoassay Methods 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 239000012452 mother liquor Substances 0.000 description 4
- 108060006184 phycobiliprotein Proteins 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 238000010998 test method Methods 0.000 description 4
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000220317 Rosa Species 0.000 description 3
- 239000005030 aluminium foil Substances 0.000 description 3
- 210000003995 blood forming stem cell Anatomy 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 238000010612 desalination reaction Methods 0.000 description 3
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 239000007850 fluorescent dye Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 241000192700 Cyanobacteria Species 0.000 description 2
- 101710135898 Myc proto-oncogene protein Proteins 0.000 description 2
- 102100038895 Myc proto-oncogene protein Human genes 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 108010004729 Phycoerythrin Proteins 0.000 description 2
- 108700020978 Proto-Oncogene Proteins 0.000 description 2
- 102000052575 Proto-Oncogene Human genes 0.000 description 2
- 241000206572 Rhodophyta Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 2
- 101710150448 Transcriptional regulator Myc Proteins 0.000 description 2
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000003139 buffering effect Effects 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 239000003431 cross linking reagent Substances 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 238000005227 gel permeation chromatography Methods 0.000 description 2
- 230000002607 hemopoietic effect Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000002906 microbiologic effect Effects 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 108010004335 phycoerythrocyanin Proteins 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000003642 reactive oxygen metabolite Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000000452 restraining effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- NWAUPHAHIDQCHS-UHFFFAOYSA-N 1,1'-biphenyl;2h-tetrazole Chemical compound C1=NN=NN1.C1=CC=CC=C1C1=CC=CC=C1 NWAUPHAHIDQCHS-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 229920002271 DEAE-Sepharose Polymers 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- 108010023321 Factor VII Proteins 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 101000971171 Homo sapiens Apoptosis regulator Bcl-2 Proteins 0.000 description 1
- 101001024703 Homo sapiens Nck-associated protein 5 Proteins 0.000 description 1
- 102100036946 Nck-associated protein 5 Human genes 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108010053210 Phycocyanin Proteins 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- 239000012506 Sephacryl® Substances 0.000 description 1
- 244000047670 Viola x wittrockiana Species 0.000 description 1
- 235000004031 Viola x wittrockiana Nutrition 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000004931 aggregating effect Effects 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- SNCZNSNPXMPCGN-UHFFFAOYSA-N butanediamide Chemical compound NC(=O)CCC(N)=O SNCZNSNPXMPCGN-UHFFFAOYSA-N 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 239000012501 chromatography medium Substances 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 238000012921 fluorescence analysis Methods 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 125000001841 imino group Chemical group [H]N=* 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000001853 liver microsome Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000004493 neutrocyte Anatomy 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 210000004976 peripheral blood cell Anatomy 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 238000006862 quantum yield reaction Methods 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- AGDSCTQQXMDDCV-UHFFFAOYSA-M sodium;2-iodoacetate Chemical compound [Na+].[O-]C(=O)CI AGDSCTQQXMDDCV-UHFFFAOYSA-M 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
Images
Landscapes
- Peptides Or Proteins (AREA)
Abstract
Description
组别 | 剂量(毫克/千克) | 动物数(只) | 平均存活天数(天) |
对照组 | 0 | 15 | 8.9±4..2 |
低剂量组 | 3 | 15 | 10.4±4.1 |
中剂量组 | 6 | 15 | 11.1±4.0 |
高剂量组 | 12 | 15 | 14.7±5.1 |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410089528 CN1786025B (zh) | 2004-12-10 | 2004-12-10 | 别藻蓝蛋白、晶体生产工艺及制品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410089528 CN1786025B (zh) | 2004-12-10 | 2004-12-10 | 别藻蓝蛋白、晶体生产工艺及制品 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1786025A CN1786025A (zh) | 2006-06-14 |
CN1786025B true CN1786025B (zh) | 2010-12-15 |
Family
ID=36783642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200410089528 Expired - Fee Related CN1786025B (zh) | 2004-12-10 | 2004-12-10 | 别藻蓝蛋白、晶体生产工艺及制品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1786025B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102462702B (zh) * | 2010-11-17 | 2015-02-11 | 远东生物科技股份有限公司 | 可抑制流感病毒血球凝集素的药物组合物及其制备方法 |
CN110669141A (zh) * | 2019-09-29 | 2020-01-10 | 杭州联科生物技术股份有限公司 | 一种别藻蓝蛋白(APC)与Annexin V蛋白偶联方法 |
-
2004
- 2004-12-10 CN CN 200410089528 patent/CN1786025B/zh not_active Expired - Fee Related
Non-Patent Citations (4)
Title |
---|
Katjusa Brejc et al..Isolation, Crystallization, Crystal Structure Analysis andRefinement of Allophycocyanin from the CyanobacteriumSpirulina platensis at 2.3 A Resoluton.J. Mol. Biol. 249.1995,(249),425页左栏第37-40页. |
Katjusa Brejc et al..Isolation, Crystallization, Crystal Structure Analysis andRefinement of Allophycocyanin from the CyanobacteriumSpirulina platensis at 2.3 A Resoluton.J. Mol. Biol. 249.1995,(249),425页左栏第37-40页. * |
彭卫民等.螺旋藻藻胆蛋白研究进展(综述).农业生物技术学报6 2.1998,6(2),173页倒数第3行-174页第6行,174页倒数第5-4行,174页倒数第16行,174页倒数第13行,174页倒数第13-11行,174页第8-9行,附图1的文字描述. |
彭卫民等.螺旋藻藻胆蛋白研究进展(综述).农业生物技术学报6 2.1998,6(2),173页倒数第3行-174页第6行,174页倒数第5-4行,174页倒数第16行,174页倒数第13行,174页倒数第13-11行,174页第8-9行,附图1的文字描述. * |
Also Published As
Publication number | Publication date |
---|---|
CN1786025A (zh) | 2006-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Landaw et al. | Catabolism of heme in vivo: comparison of the simultaneous production of bilirubin and carbon monoxide | |
Weatherall et al. | The pattern of disordered haemoglobin synthesis in homozygous and heterozygous β‐thalassaemia | |
CN103402526B (zh) | 组蛋白抑制 | |
CN1786025B (zh) | 别藻蓝蛋白、晶体生产工艺及制品 | |
CN101962402B (zh) | 一种黄芪糖蛋白及其制备方法和用途 | |
CN1786024B (zh) | 藻红蛋白、晶体生产工艺及制品 | |
Morgan et al. | A specific blood group O substance | |
CN106075436A (zh) | 一种不含抗生素的抗幽门螺杆菌口服制剂 | |
SU1767433A1 (ru) | Способ определени инсулинорезистентности имунного генеза у больных сахарным диабетом I типа | |
Kitadi et al. | Mineral content and antisickling activity of Annona senegalensis, Alchornea cordifolia and Vigna unguiculata used in the management of sickle cell disease in the Kwilu Province (Congo, DR) | |
Ershoff et al. | Biological evaluation of crystalline fraction I protein from tobacco | |
Baud et al. | Specificity and cellular distribution of human polymorphonuclear leucocyte receptors for leukotriene C4. | |
CN1243015C (zh) | 一种微藻藻红蛋白分离纯化方法 | |
KR100207040B1 (ko) | 미네랄, 생약재엑기스 및 아미노산이 함유된 건강식품조성물 | |
CN1786026B (zh) | 荧光藻蓝蛋白、晶体的生产工艺及制品 | |
Makinde et al. | Gossypol-induced erythrocyte fragility in the rat is ameliorated by ethanol intake. | |
CN102690339B (zh) | 鼠尾藻凝集素及制备方法 | |
Björnsson et al. | Effects of duodenal perfusion with sodium taurocholate on biliary and pancreatic secretion in man | |
WO2019193614A2 (en) | The process of achieving the highest degree of drug's purity of c-phycocyanin from spirulina alga | |
CN107266545B (zh) | 一种用膜荚黄芪种子提取膜荚黄芪凝集素蛋白的方法及应用 | |
Kanabrocki et al. | Circadian characteristics of dialyzable and non-dialyzable human urinary electrolytes, trace elements and total solids | |
CN105175567A (zh) | 鳄鱼血多糖的提取方法及其在肺癌治疗中的应用 | |
Archer et al. | Tissue Distribution of 125I-Toluidine Blue in the Rat | |
CN108057037A (zh) | 一种用于制备抑制弓形虫增殖的小分子抑制剂的应用 | |
Gounalan et al. | Effect of bracken (Pteridium a quilinum) and dryopteris (Dryopteris juxtaposita) fern toxicity in laboratory rabbits |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: LUO JIANHUA Free format text: FORMER OWNER: LIU WEIGUO Effective date: 20080118 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20080118 Address after: 376, West Lake village, new town, Panan County, Zhejiang Province, China: 322305 Applicant after: Luo Jianhua Address before: Room two, room 602, building 21, Tianma garden, Zhejiang, Zhuji Province, China: 311800 Applicant before: Liu Weiguo |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: FUJIAN SHENLIU HEALTH FOOD CO., LTD. Free format text: FORMER OWNER: LUO JIANHUA Effective date: 20140117 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 322305 JINHUA, ZHEJIANG PROVINCE TO: 350313 NANPING, FUJIAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140117 Address after: 350313 Nanping City, Fujian province Shunchang County Sha Dun Six Biological Park Patentee after: FUJIAN SHENLIU HEALTHY FOOD CO.,LTD. Address before: 322305 No. 376, West Lake village, new town, Panan County, Zhejiang Patentee before: Luo Jianhua |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Production technology of allophycocyanin and crystal and product thereof Effective date of registration: 20150421 Granted publication date: 20101215 Pledgee: China Co. truction Bank Corp Shunchang branch Pledgor: FUJIAN SHENLIU HEALTHY FOOD CO.,LTD. Registration number: 2015350000024 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20101215 |
|
CF01 | Termination of patent right due to non-payment of annual fee |